1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ascendis Pharma AS (ASND)
  7. Financials

ASND

Ascendis Pharma AS
108.14
0.00 (0.00%)
Upgrade to Real-Time

Ascendis Pharma A/S (ASND) Fundamentals
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.
SHARE INFORMATION
Market CapUS$ 6,180,449,181
Shares Outstanding57,152,295
Float57,152,295
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 54,891,791
Latest Fiscal EPSUS$ -11.16
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions432
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months6,198,932
Institutional Holdings Percent71.2%
Institutional Sold Previous 3 Months5,175,728
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week HighUS$ 134.53
52 Week LowUS$ 61.58
52 Week High ChangeUS$ -8.73
21 Day Moving AverageUS$ 111.4588
21 Day Extended Moving AverageUS$ 111.2069
50 Day Moving AverageUS$ 115.4157
50 Day Extended Moving AverageUS$ 113.7754
200 Day Moving AverageUS$ 106.1077
200 Day Extended Moving AverageUS$ 112.3217
10 Day Average Volume244,286
20 Day Average Volume255,243
30 Day Average Volume252,655
50 Day Average Volume267,855
Alpha0.012497
Beta0.5474
Standard Deviation0.127590
R20.053374
7 Day Price ChangeUS$ 1.93
7 Day Percent Change1.82%
21 Day Price ChangeUS$ -5.25
21 Day Percent Change-4.63%
30 Day Price ChangeUS$ -8.51
30 Day Percent Change-7.3%
Month to Date Price ChangeUS$ -2.95
Month to Date Percent Change-2.66%
Quarter to Date Price ChangeUS$ -13.99
Quarter to Date Percent Change-11.46%
180 Day Price ChangeUS$ 0.81
180 Day Percent Change0.75%
200 Day Price ChangeUS$ 20.17
200 Day Percent Change22.93%
Year to Date Price ChangeUS$ -13.99
Year to Date Percent Change-11.46%

Ascendis Pharma A/S (ASND) Key Ratios

PROFITABILITY
EBIT Margin-1,372.2%
EBITDA Margin-1,319.1%
Pre-Tax Profit Margin-2,438.2%
Profit Margin Count0.0%
Gross Margin76.3%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 56,175,433
Revenue Per ShareUS$ 0.9829
Revenue (3 Years)US$ 75.38
Revenue (5 Years)US$ 5.65
FINANCIAL STRENGTH
Price to Tangible Book22.60
Total Debt To Equity1.90
Int Coverage-11.50
Current Ratio5.40
Leverage Ratio2.50
Quick Ratio4.40
Long Term Debt To Capital0.65
VALUATION MEASURES
PE Ratio-10.00
Enterprise ValueUS$ 5,939,444,484
Price to Sales110.0205
Price to Free Cash-10.90
PE High Last 5 Years-17.30
Price To Book22.50
Price To Cash Flow0.00
PE Low Last 5 Years-17.50
Price to Tangible Book22.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.20
Invoice Turnover0.10
Assets Turnover0.00
Return Assets-53.64
Return on Equity-101.69
Return on Capital-46.18

Ascendis Pharma A/S (ASND) Profile

PROFILE INFO
Issue TypeAD
SEC TypeDR
AuditorDeloitte Statsautoriseret Revisionspartnerselskab
CEOJan Moller Mikkelsen
Emplyoees797
Last AuditUQ
CIK0001612042
IndustryBiotechnology
SectorHealthcare
NAICSMedicinal and Botanical Manufacturing(325411)
CONTACT INFO
AddressTuborg Boulevard 12
Hellerup, DK-2900
Websitehttp://www.ascendispharma.com
Facsimile+45 36944010
Telephone+45 70222244
Emailir@ascendispharma.com
Your Recent History
NASDAQ
ASND
Ascendis P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230320 08:58:26